| SpectraBase Spectrum ID |
I7g5v3oY7qw |
| Name |
Phenmetrazine I |
| Classification |
Pharmaceutical drug, anorectic |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| DEA Citation |
21 CFR §1308.12 (d) (3) |
| DEA Controlled Substance Name |
Phenmetrazine |
| DEA Controlled Substance Type |
Salts |
| DEA Controlled Substances Code Number |
1631 |
| DEA Schedule |
Schedule II |
| DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system |
| Exact Mass |
177.115364106 u |
| Formula |
C11H15NO |
| InChI |
InChI=1S/C11H15NO/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10/h2-6,9,11-12H,7-8H2,1H3/t9-,11+/m0/s1 |
| InChIKey |
OOBHFESNSZDWIU-GXSJLCMTSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
177.247 g/mol |
| Nominal Mass |
177 u |
| Quality |
987 |
| Retention Index |
1431 |
| SMILES |
[C@]1([C@@](NCCO1)(C)[H])(C=1C=CC=CC1)[H] |
| SPLASH |
splash10-05fu-9000000000-c5fc17ebafced1a936ea |
| Sample Comments |
Stereo configuration unknown |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Dex-phenmetrazin
Fenmetralin
Fenmetrazin
Oxazimedrin
Phenmetralin
3-Methyl-2-phenyl-morpholine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011096 |
